Bionexo

What Bionexo does

Bionexo is a São Paulo–headquartered healthtech platform that connects buyers and suppliers across the Latin American healthcare ecosystem. Founded in 1998 and backed by Bain Capital, the company serves more than 11,000 clients including hospitals, clinics, laboratories, health insurance operators, distributors, and industry across Brazil, Argentina, Colombia, Mexico, and Ecuador, reaching over 90 million patients and 1.2 million users through its platforms. It operates the largest healthcare B2B marketplace in Latin America, with 4,500+ connected institutions and 35+ suppliers transacting through it.

The product portfolio is structured as a platform-plus-modules architecture. Bionexo 360° is the integrated Plan-to-Cash system covering procurement, marketplace purchasing, electronic invoicing (BioNFe), OPME management, RFID traceability (Biotracker), eligibility, billing, and denial appeals. Tasy — acquired from Philips for $193 million in 2026 and the first EMR regularized as a medical device by ANVISA in Brazil — adds clinical, operational, and financial hospital management with modules for oncology, radiology (RIS), laboratories (LIS), primary care, and health insurance operators. Clínica nas Nuvens provides a cloud-based clinic ERP, while Brasíndice (integrated in 2025, with a 60+ year history) delivers the national pharmaceutical pricing reference. The LIA AI layer, with 20+ specialized agents for purchasing, RCM, and clinical workflows, sits across the stack and is complemented by acquired capabilities (Avatar, Tradimus, Overmind, BeeCare) for revenue cycle management and RPA. All cloud infrastructure runs on Oracle Cloud with LGPD compliance.

Bionexo monetizes through SaaS subscriptions for Tasy, Bionexo 360°, and Clínica nas Nuvens; transaction fees on the healthcare marketplace; Brasíndice subscriptions across Basic, Intermediate, Advanced, and printed tiers; and professional services for implementation and customization. Distribution is primarily enterprise field sales supplemented by self-serve platform access, with localized support offices in each of the five operating countries. Pricing is quote-based for enterprise solutions, while Brasíndice pricing is publicly disclosed. The company is privately held by Bain Capital and is pursuing an active M&A strategy, having completed multiple acquisitions since 2022 to expand its RCM, financial, and clinical capabilities.

Name

Bionexo

Legal name

BIONEXO S.A.

Website

https://bionexo.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

251–500 employees

Short description

Bionexo is a Brazil-headquartered healthtech that operates an integrated healthcare platform connecting hospitals, clinics, laboratories, operators, and suppliers across five Latin American countries through supply chain, revenue cycle, clinical, and AI solutions.

Ownership category

akta.pro rank

Product category

Healthcare SaaS / Hospital Management Software

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL)

akta.pro secondary industries

Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Pharmaceuticals & Life Sciences Forwarding (GxP/GDP) (TLACAJAB), Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Healthcare SaaS platform
• Hospital management software
• Healthcare supply chain
• Revenue cycle management
• Electronic medical records

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices6 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. SaaS Subscription Licensing: Software licensing fees for access to Bionexo 360°, Tasy, Clínica nas Nuvens, and other digital health solutions. Delivered as subscription-based licensing with annual or multi-year contract terms.
2. Healthcare Marketplace Transaction Fees: B2B marketplace connecting healthcare suppliers and buyers. The platform processes purchases and transactions for the largest healthcare marketplace in Latin America.
3. Brasíndice Subscriptions: Pricing reference database subscriptions with multiple tiers: Basic Online, Intermediate Online (with data export by state), Advanced Online (with national data export), and printed magazine subscriptions.
4. Professional Services: Implementation services, training, customization, and additional support services for platform deployment.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Core offering

Bionexo is a Latin American healthtech platform that develops and operates digital solutions for healthcare institutions. Its portfolio includes Bionexo 360° (an integrated supply chain to revenue cycle platform and B2B healthcare marketplace), Tasy (an ANVISA-certified hospital and clinical management system with electronic medical records), Clínica nas Nuvens (cloud-based clinic ERP), Brasíndice (national pharmaceutical pricing reference since 1965), and the LIA AI layer. The company connects hospitals, clinics, laboratories, health insurance operators, distributors and suppliers across Brazil, Argentina, Colombia, Mexico and Ecuador.

Product overview

Bionexo is a comprehensive health technology platform in Latin America operating under a platform-plus-modules architecture. The core offerings include Bionexo 360° (an integrated Plan to Cash platform connecting supplies to financial operations) and Tasy (a complete integrated health management system for operators and providers). These platforms are supplemented by specialized modules including Tasy RIS for radiology, Tasy LIS for laboratories, Tasy Oncology for chemotherapy management, and Clínica nas Nuvens for cloud-based clinic management. The product portfolio also includes acquired brands like Avatar and Tradimus for revenue cycle management, Brasíndice (pricing reference since 1965), Bioanalytics for market intelligence, Biotracker for RFID traceability, BioNFe for electronic invoices, BioPay for financial management, and Overmind for RPA automation. The AI layer LIA (Lenguaje Inteligente Analítico) powers intelligent agents across the ecosystem for process automation, optimization, and predictive analytics. The company serves hospitals, clinics, laboratories, health insurance operators, distributors, and healthcare industry across Brazil, Argentina, Colombia, Mexico, and Ecuador.

Differentiator

Problem solved

Functional benefit

Brands

• Tasy: Integrated health management system for operators and healthcare providers, including electronic medical records, hospital management, and clinical operations.
• Clínica nas Nuvens
• Brasíndice
• LIA (Linguagem Inteligente Analítico)
• Bionexo 360°

Products and services

• Bionexo 360°

Quantifiable outcome

• 14.1% savings in purchasing costs (Unimed Piracicaba)
• +11 more outcomes

Named customers17 records

Segments10 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability9 records

Feature11 records

Partnerships

Six partnerships are on record, tiered flagship, core and strategic.

• PhilipsflagshipStrategic or Co-development Partner · 1 January 2026Bionexo acquired Philips' Brazilian EMR business Tasy for $193 million. This strategic acquisition significantly expanded Bionexo's hospital management capabilities and customer base in Latin America.
• Semantix, Inc.coreTechnology or IntegrationAcquired Tradimus Consultoria e Serviços em T.i. Ltda. from Semantix, Inc. Semantix is a Brazil-based data platform developer specializing in digital transformation and data analytics solutions.
• Avatar SoluçõescoreStrategic or Co-development PartnerBionexo acquired 100% of Avatar, a healthtech company specializing in SaaS solutions for revenue cycle management. Founded in 2017, based in São Paulo, focused on automating medical billing processes.
• TradimuscoreStrategic or Co-development PartnerBionexo announced acquisition of Tradimus, a company focused on financial and operational efficiency solutions for hospitals, clinics, and laboratories. Deal pending CADE regulatory approval. Adds R$8 billion in processed medical accounts annually.
• Oracle CloudcoreTechnology or IntegrationInfrastructure provider for Bionexo's cloud solutions. All solutions are hosted on Oracle Cloud infrastructure ensuring security, scalability, and reliability.
• FIPE (Fundação Instituto de Pesquisas Econômicas)strategicStrategic or Co-development PartnerPartnership for healthcare price indices development. Created IPMH (Índice de Preços de Medicamentos e Materiais Hospitalares) and OPME index in alliance with FIPE.

Scale indicators23 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• MV Sistemas (MV Saúde): Brazilian hospital information system provider serving hospitals and health operators across Latin America. Directly competes with Bionexo's Tasy and Bionexo 360° in the integrated HIS/RCM category for Brazilian healthcare institutions.
• Pixeon: Brazilian healthcare IT company specializing in radiology (PACS/RIS) and laboratory information systems. Directly overlaps with Bionexo's Tasy RIS and Tasy LIS modules in the diagnostic imaging and clinical lab segments.
• Waystar: US healthcare revenue cycle management platform serving hospitals and health systems. Directly comparable to Bionexo's Avatar, Tradimus, and Bionexo 360° revenue cycle offerings, providing a benchmark for global RCM software economics.
• R1 RCM: Hospital-focused revenue cycle management company (taken private by TowerBrook/CD&R in 2024). Operates in the same end-to-end RCM category as Bionexo's Avatar and Tradimus solutions, with comparable customer base of US health systems.

Broad incumbents

• TOTVS: Brazil's largest enterprise software vendor with a healthcare vertical (TOTVS Saúde). Operates across ERP, HR, and healthcare management — overlapping with Bionexo's broader clinic and hospital management portfolio but not specializing in Bionexo's niche.
• Philips (Health Technology): Global health technology company that divested its Brazilian EMR business (Tasy) to Bionexo for $193M. Continues to operate in adjacent areas (diagnostic imaging, patient monitoring) where Bionexo's installed base competes for capital budgets.
• Oracle Health (Cerner): Global EMR and healthcare IT giant post-Cerner acquisition. Operates broadly across hospital information systems worldwide and represents a major incumbent competitor if it chose to deepen presence in the Brazilian/LatAm market.
• Epic Systems: US-based EMR leader serving large academic medical centers and health systems. While not actively commercializing in Brazil, Epic represents the global benchmark for integrated EMR and could expand into LatAm via large hospital partnerships.
• GE HealthCare: Global medical imaging, monitoring, and healthcare IT vendor. Overlaps with Bionexo's Tasy RIS/radiology and LIS modules as part of a broader imaging and diagnostics portfolio, particularly in enterprise hospital deals.
• Veradigm (formerly Allscripts): US-listed healthcare IT vendor with ambulatory EHR, practice management, and revenue cycle solutions. Broad incumbent in healthcare IT that shares comparable RCM and clinical management capabilities with Bionexo's portfolio.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/bionexodobrasil
• Facebookfacebook.com/bionexo
• LinkedInlinkedin.com/company/bionexo
• Instagraminstagram.com/bionexooficial
• Xx.com/bionexo_

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionexo